NO174351C - Fremgangsmåte for fremstilling av human insulinforlöper samt DNA-sekvens og vektor til anvendelse av fremgangsmåten - Google Patents

Fremgangsmåte for fremstilling av human insulinforlöper samt DNA-sekvens og vektor til anvendelse av fremgangsmåten

Info

Publication number: NO174351C
Authority: NO; Norway
Prior art keywords: chain; human insulin; vector; well; dna sequence
Prior art date: 1984-05-30

Application number

NO852132A

Other languages

English (en)

Norwegian (no)

Other versions

NO174351B (no

NO852132L (no

Inventor

Jan Markussen

Niels Fiil

Mogens Trier Hansen

Lars Thim

Kjeld Norris

Hans Ole Voigt

Gustav Ammerer

Original Assignee

Novo Nordisk As

Novo Industri As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-05-30

Filing date

1985-05-29

Publication date

1994-04-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26064247&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO174351(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1984-05-30 Priority claimed from DK266584A external-priority patent/DK266584D0/da

1985-05-29 Application filed by Novo Nordisk As, Novo Industri As filed Critical Novo Nordisk As

1985-12-02 Publication of NO852132L publication Critical patent/NO852132L/no

1994-01-10 Publication of NO174351B publication Critical patent/NO174351B/no

1994-04-20 Publication of NO174351C publication Critical patent/NO174351C/no

Links

101000976075 Homo sapiens Insulin Proteins 0.000 title abstract 4
PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 title abstract 4
239000002243 precursor Substances 0.000 title abstract 4
108091028043 Nucleic acid sequence Proteins 0.000 title abstract 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 4
102000004877 Insulin Human genes 0.000 abstract 2
108090001061 Insulin Proteins 0.000 abstract 2
125000000539 amino acid group Chemical group 0.000 abstract 2
229940125396 insulin Drugs 0.000 abstract 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
238000006243 chemical reaction Methods 0.000 abstract 1
238000012258 culturing Methods 0.000 abstract 1
238000000338 in vitro Methods 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
- C12N15/69—Increasing the copy number of the vector
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
- Y10S435/94—Saccharomyces
- Y10S435/942—Saccharomyces cerevisiae

Landscapes

Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Mycology (AREA)
Diabetes (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Endocrinology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

NO852132A 1984-05-30 1985-05-29 Fremgangsmåte for fremstilling av human insulinforlöper samt DNA-sekvens og vektor til anvendelse av fremgangsmåten NO174351C (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DK266584A DK266584D0 (da)	1984-05-30	1984-05-30	Dna-sekvens, der koder for en biosyntetisk insulinprecursor og fremgangsmaade til fremstilling af insulinprecursoren
DK58285A DK58285D0 (da)	1984-05-30	1985-02-08	Peptider samt fremstilling og anvendelse deraf

Publications (3)

Publication Number	Publication Date
NO852132L NO852132L (no)	1985-12-02
NO174351B NO174351B (no)	1994-01-10
NO174351C true NO174351C (no)	1994-04-20

Family

ID=26064247

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO852132A NO174351C (no)	1984-05-30	1985-05-29	Fremgangsmåte for fremstilling av human insulinforlöper samt DNA-sekvens og vektor til anvendelse av fremgangsmåten

Country Status (15)

Country	Link
US (1)	US4916212A (de)
EP (2)	EP0163529B1 (de)
JP (4)	JPH0630613B2 (de)
AT (1)	ATE143374T1 (de)
AU (1)	AU590197B2 (de)
CA (1)	CA1304022C (de)
DE (2)	DE3583824D1 (de)
DK (2)	DK58285D0 (de)
ES (2)	ES8609483A1 (de)
FI (1)	FI89183C (de)
GR (1)	GR851304B (de)
IE (1)	IE66387B1 (de)
NO (1)	NO174351C (de)
NZ (1)	NZ212243A (de)
PT (1)	PT80551B (de)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4946828A (en) *	1985-03-12	1990-08-07	Novo Nordisk A/S	Novel insulin peptides
US5008241A (en) *	1985-03-12	1991-04-16	Novo Nordisk A/S	Novel insulin peptides
DK129385A (da) *	1985-03-22	1986-09-23	Novo Industri As	Peptider og fremstilling deraf
PH25772A (en) *	1985-08-30	1991-10-18	Novo Industri As	Insulin analogues, process for their preparation
US4963665A (en) *	1986-01-07	1990-10-16	Washington University	Human preproinsulin-like growth factor I
DK437786D0 (da) *	1986-09-12	1986-09-12	Nordisk Gentofte	Insulinprecursorer
DK450187D0 (da) *	1987-08-28	1987-08-28	Novo Industri As	Fremgangsmaade til fremstilling af proteiner
DK463887D0 (da) *	1987-09-07	1987-09-07	Novo Industri As	Gaerleader
US4904584A (en) *	1987-12-23	1990-02-27	Genetics Institute, Inc.	Site-specific homogeneous modification of polypeptides
DK336188D0 (da) *	1988-06-20	1988-06-20	Nordisk Gentofte	Propeptider
ATE101620T1 (de) *	1988-06-23	1994-03-15	Hoechst Ag	Mini-proinsulin, seine herstellung und verwendung.
US6875589B1 (en)	1988-06-23	2005-04-05	Hoechst Aktiengesellschaft	Mini-proinsulin, its preparation and use
US5716927A (en) *	1988-12-23	1998-02-10	Novo Nordisk A/S	Insulin analogs having a modified B-chain
DE3844211A1 (de) *	1988-12-29	1990-07-05	Hoechst Ag	Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
DK105489D0 (da) *	1989-03-03	1989-03-03	Novo Nordisk As	Polypeptid
DK134189D0 (da) *	1989-03-20	1989-03-20	Nordisk Gentofte	Insulinforbindelser
AU9172991A (en)	1990-12-07	1992-07-08	Cnc Development, Inc.	Catalytic chemical reactor
FR2686899B1 (fr)	1992-01-31	1995-09-01	Rhone Poulenc Rorer Sa	Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
CA2089541A1 (en)	1992-02-18	1993-08-19	Bruce H. Frank	Selective removal of n-terminal extensions from folded insulin precursors using dipeptidyl-aminopeptidase-1
US6001604A (en) *	1993-12-29	1999-12-14	Bio-Technology General Corp.	Refolding of proinsulins without addition of reducing agents
US6500645B1 (en)	1994-06-17	2002-12-31	Novo Nordisk A/S	N-terminally extended proteins expressed in yeast
US5891680A (en) *	1995-02-08	1999-04-06	Whitehead Institute For Biomedical Research	Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12
KR0150565B1 (ko) *	1995-02-15	1998-08-17	김정재	유전자 조환에 의한 사람 인슐린 전구체의 제조 및 이를 이용한 인슐린의 제조방법
WO1996029397A1 (en)	1995-03-17	1996-09-26	Novo Nordisk A/S	Novel endoglucanases
IL118127A0 (en) *	1995-05-05	1996-09-12	Lilly Co Eli	Single chain insulin with high bioactivity
GB9513967D0 (en) *	1995-07-08	1995-09-06	Univ Leicester	Insulin
US5840542A (en) *	1995-07-28	1998-11-24	Mogam Biotechnology Research Institute	Method for manufacture of proinsulin with high export yield
CZ297338B6 (cs)	1996-03-01	2006-11-15	Novo Nordisk A/S	Peptid potlacující chut k jídlu, farmaceutický prostredek jej obsahující a jeho pouzití
DK1066328T3 (da) *	1998-03-31	2009-02-09	Tonghua Gantech Biotechnology	Kimært protein, der indeholder en intramolekylær chaperon-lignende sekvens, og dets anvendelse til insulinproduktion
CN1125081C (zh)	1999-09-08	2003-10-22	中国科学院上海生物化学研究所	重组天然和新型人胰岛素及其制备方法
WO2001046453A1 (en)	1999-12-22	2001-06-28	Novo Nordisk A/S	Method for extractive refolding of scrambled single-chain polypeptides
US6521738B2 (en)	1999-12-29	2003-02-18	Novo Nordisk A/S	Method for making insulin precursors and insulin precursor analogs
US7378390B2 (en)	1999-12-29	2008-05-27	Novo Nordisk A/S	Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
KR20030004315A (ko)	1999-12-29	2003-01-14	노보 노르디스크 에이/에스	효모에서 개선된 발효 수율을 갖는 인슐린 선구물질 및인슐린 선구물질 유사체의 제조 방법
HUP0203475A3 (en) *	1999-12-29	2005-11-28	Novo Nordisk As	Method for making insulin precursors and insulin precursor analogs
US6777207B2 (en)	1999-12-29	2004-08-17	Novo Nordisk A/S	Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
JP2003528149A (ja)	2000-03-24	2003-09-24	ジェネンテック・インコーポレーテッド	軟骨性疾患の治療のためのインスリンの使用
US20050100991A1 (en) *	2001-04-12	2005-05-12	Human Genome Sciences, Inc.	Albumin fusion proteins
JP2003530838A (ja) *	2000-04-12	2003-10-21	ヒューマンゲノムサイエンシズインコーポレイテッド	アルブミン融合タンパク質
AR025646A1 (es) *	2000-09-13	2002-12-04	Beta Lab Sa	Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.
KR100449454B1 (ko) *	2000-10-02	2004-09-21	이현철	단일사슬 인슐린 유도체의 유전자를 포함하는 당뇨병치료용 벡터
US20020164712A1 (en) *	2000-12-11	2002-11-07	Tonghua Gantech Biotechnology Ltd.	Chimeric protein containing an intramolecular chaperone-like sequence
CZ20032454A3 (en)	2001-03-22	2004-03-17	Novo Nordisk Health Care Ag	Coagulation factor vii derivative
US7105314B2 (en)	2001-04-02	2006-09-12	Novo Nordisk A/S	Method for making human insulin precursors
WO2002079250A1 (en) *	2001-04-02	2002-10-10	Novo Nordisk A/S	Insulin precursors and a process for their preparation
CA2446739A1 (en) *	2001-05-25	2002-12-05	Human Genome Sciences, Inc.	Chemokine beta-1 fusion proteins
ES2376694T3 (es)	2001-09-27	2012-03-16	Novo Nordisk Health Care Ag	Polipã‰ptidos del factor vii de coagulaciã“n humano.
AU2002364587A1 (en) *	2001-12-21	2003-07-30	Human Genome Sciences, Inc.	Albumin fusion proteins
ES2425738T3 (es) *	2001-12-21	2013-10-17	Human Genome Sciences, Inc.	Proteínas de fusión de la albúmina
EP1604008B1 (de)	2002-09-13	2010-12-22	Cornell Research Foundation, Inc.	Verwendung von mutationen zur verbesserung von aspergillus-phytasen
WO2004024862A2 (en) *	2002-09-13	2004-03-25	Wockhardt Limited	Yeast protein expression secretion system
EP1594530A4 (de)	2003-01-22	2006-10-11	Human Genome Sciences Inc	Albuminfusionsproteine
WO2004085472A1 (en) *	2003-03-27	2004-10-07	Novo Nordisk A/S	Method for making human insulin precursors and human insulin
ES2313018T3 (es)	2003-06-17	2009-03-01	Sembiosys Genetics Inc.	Procedimiento de produccion de insulina en plantas.
ATE547519T1 (de)	2003-09-09	2012-03-15	Novo Nordisk Healthcare Ag	Gerinnungsfaktor-vii-polypeptide
EP1687428A1 (de) *	2003-11-14	2006-08-09	Novo Nordisk A/S	Verfahren zur herstellung von acyliertem insulin
JP5697831B2 (ja) *	2003-12-03	2015-04-08	ノヴォノルディスクアー／エス	単鎖インシュリン
JP5410020B2 (ja)	2005-02-02	2014-02-05	ノヴォノルディスクアー／エス	インスリン誘導体
EP2256130B1 (de)	2005-02-02	2013-09-25	Novo Nordisk A/S	Neuartige Insulinderivate
BRPI0609079A2 (pt)	2005-04-18	2010-11-16	Novo Nordisk As	peptìdeo, composição farmacêutica, método para o tratamento de cáncer, uso de um peptìdeo construto de ácido nucleico, vetor, hospedeiro, e, anticorpo
CN101243190B (zh)	2005-08-16	2015-05-13	诺沃-诺迪斯克有限公司	制备成熟胰岛素多肽的方法
JP5690047B2 (ja)	2005-09-14	2015-03-25	ノボノルディスクヘルスケアアーゲー	ヒト凝固第ｖｉｉ因子ポリペプチド
EP1996709A2 (de) *	2006-03-13	2008-12-03	Novo Nordisk A/S	Acyliertes, einkettiges insulin
EP2404934A1 (de)	2006-09-22	2012-01-11	Novo Nordisk A/S	Proteaseresistente Insulinanaloga
US8518668B2 (en)	2006-09-27	2013-08-27	Novo Nordisk A/S	Method for making maturated insulin polypeptides in a fungal cell
WO2008062010A2 (en)	2006-11-22	2008-05-29	Novo Nordisk A/S	Method for making activated carboxypeptidases
US10100098B2 (en)	2006-12-13	2018-10-16	Stelis Biopharma Private Limited	Insulin production methods and proinsulin constructs
US7790677B2 (en) *	2006-12-13	2010-09-07	Elona Biotechnologies	Insulin production methods and pro-insulin constructs
ES2558930T3 (es)	2007-08-13	2016-02-09	Novo Nordisk A/S	Análogos de la insulina de acción rápida
CN101784563B (zh)	2007-08-15	2015-02-04	诺沃-诺迪斯克有限公司	具有包括含亚烷基二醇的氨基酸的重复单位的酰基部分的胰岛素
KR20100053561A (ko)	2007-08-15	2010-05-20	노보 노르디스크 에이/에스	아실 및 알킬렌 글리콜 부분을 갖는 인슐린 유사체
WO2009101672A1 (ja) *	2008-02-12	2009-08-20	Itoham Foods Inc.	高発現分泌インスリン前駆体を含む融合タンパク質、それをコードするｄｎａおよびインスリンの製造方法
ES2563553T3 (es)	2008-04-01	2016-03-15	Novo Nordisk A/S	Conjugados de insulina-albúmina
US20120107267A1 (en)	2009-03-11	2012-05-03	Novo Nordisk A/S	Interleukin-21 variants having antagonistic binding to the il-21 receptor
KR101775000B1 (ko)	2009-06-26	2017-09-04	노보 노르디스크 에이/에스	인슐린, 니코틴아미드 및 아미노산을 포함하는 제제
US20120282285A1 (en)	2009-07-17	2012-11-08	Rigshospitalet	Masp isoforms as inhibitors of complement activation
JP5931738B2 (ja)	2009-12-01	2016-06-08	ノヴォノルディスクアー／エス	新規のペプチジルアルファ−ヒドロキシグリシンアルファ−アミド化リアーゼ
AU2011222883B2 (en)	2010-03-05	2016-05-26	Omeros Corporation	Chimeric inhibitor molecules of complement activation
EP2585484A1 (de) *	2010-06-23	2013-05-01	Novo Nordisk A/S	Zusätzliche disulfidbindungen enthaltende insulinanaloga
EP2585483A1 (de)	2010-06-23	2013-05-01	Novo Nordisk A/S	Humane insulinanaloga mit zusätzlichen disulfid-bindungen
WO2011161125A1 (en)	2010-06-23	2011-12-29	Novo Nordisk A/S	Insulin derivatives containing additional disulfide bonds
CN103328006A (zh)	2010-12-14	2013-09-25	诺沃—诺迪斯克有限公司	包含胰岛素、烟酰胺和氨基酸的制剂
US20130331320A1 (en)	2010-12-14	2013-12-12	Novo Nordisk A/S	Fast-acting insulin in combination with long-acting insulin
WO2012123519A2 (en)	2011-03-15	2012-09-20	Novo Nordisk A/S	Human insulin analogues and derivatives comprising cysteine substitutions
CN102675452B (zh)	2011-03-17	2015-09-16	重庆富进生物医药有限公司	具持续降血糖和受体高结合的人胰岛素及类似物的偶联物
CN103596584B (zh)	2011-06-15	2016-12-14	诺沃—诺迪斯克有限公司	多取代的胰岛素
ES2676029T3 (es)	2012-02-09	2018-07-16	Var2 Pharmaceuticals Aps	Direccionamiento de glicanos de sulfato de condroitina
WO2013186138A1 (en)	2012-06-14	2013-12-19	Novo Nordisk A/S	Preparation comprising insulin, nicotinamide and arginine
EP2906693A1 (de)	2012-10-15	2015-08-19	Novo Nordisk Health Care AG	Gerinnungsfaktor-vii-polypeptide
JP6735561B2 (ja)	2012-12-03	2020-08-05	メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋＳｈａｒｐ＆ＤｏｈｍｅＣｏｒｐ．	Ｏ−グリコシル化カルボキシ末端部分（ｃｔｐ）ペプチド系のインスリンおよびインスリン類似体
US9867869B2 (en)	2012-12-12	2018-01-16	Massachusetts Institute Of Technology	Insulin derivatives for diabetes treatment
JP2016521701A (ja)	2013-06-07	2016-07-25	ノヴォノルディスクアー／エス	成熟インスリンポリペプチドを作製するための方法
GB201321489D0 (en)	2013-12-05	2014-01-22	Chemical & Biopharmaceutical Lab Of Patras S A	Biologically active insulin derivatives
PL233560B1 (pl)	2014-12-05	2019-10-31	Mabion Spolka Akcyjna	Sposób otrzymywania insuliny lub analogu insuliny z prekursora rekombinowanego białka
EA037848B1 (ru)	2016-07-14	2021-05-27	Общество С Ограниченной Ответственностью "Биохимический Агент"	Гибридный белок, полинуклеотид, генетическая конструкция, продуцент, препарат для регенерации хряща (варианты)
US11230585B2 (en)	2016-09-06	2022-01-25	Chemical & Biopharmaceutical Laboratories Of Patra	Proinsulin derivatives
PE20211264A1 (es)	2017-08-17	2021-07-15	Novo Nordisk As	Analogos de insulina acilados novedosos y usos de estos
EP3821244A1 (de)	2018-07-13	2021-05-19	Varct Diagnostics ApS	Isolierung von zirkulierenden zellen fetalen ursprungs unter verwendung von rekombinantem malaria-protein var2csa
US12325732B2 (en)	2018-09-12	2025-06-10	Amphastar Nanjing Pharmaceuticals Inc	Pro-insulin aspart structure and method for preparing insulin aspart
CN118772259A (zh)	2019-12-30	2024-10-15	甘李药业股份有限公司	胰岛素衍生物
CN119060162A (zh)	2019-12-30	2024-12-03	甘李药业股份有限公司	长效glp-1化合物
WO2022049409A1 (en)	2020-09-02	2022-03-10	Sia Terragen	Express diagnosticum for sars-cov-2
WO2023144240A1 (en)	2022-01-26	2023-08-03	Novo Nordisk Research Centre Oxford Limited	Glucose sensitive insulin derivatives and uses thereof
EP4471053A1 (de)	2022-01-28	2024-12-04	Gan & Lee Pharmaceuticals Co., Ltd.	Acyliertes insulin

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4440859A (en) *	1977-05-27	1984-04-03	The Regents Of The University Of California	Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms
US4411994A (en) *	1978-06-08	1983-10-25	The President And Fellows Of Harvard College	Protein synthesis
US4431740A (en) *	1979-09-12	1984-02-14	The Regents Of The University Of California	DNA Transfer vector and transformed microorganism containing human proinsulin and pre-proinsulin genes
US4343898A (en) *	1980-02-11	1982-08-10	Novo Industri A/S	Process for preparing esters of human insulin
CA1202581A (en) *	1980-03-27	1986-04-01	Saran A. Narang	Adaptor molecules for dna and their application to synthesis of gene-derived products
CA1154435A (en) *	1980-03-27	1983-09-27	Bruce H. Frank	Process for producing an insulin precursor
ZA811895B (en) *	1980-04-07	1982-04-28	Univ California	Expression of hormone genomic clones
JPS5750948A (en) *	1980-09-12	1982-03-25	Shionogi & Co Ltd	Insulin analog and preparation
NZ199391A (en) *	1981-01-02	1985-12-13	Genentech Inc	Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
NZ199722A (en) *	1981-02-25	1985-12-13	Genentech Inc	Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
IE52768B1 (en) *	1981-04-06	1988-02-17	Boots Co Ltd	1-arylcyclobutylalkylamine compounds useful as therapeutic agents
CA1204682A (en) *	1981-06-19	1986-05-20	Saran A. Narang	Adaptors, and synthesis and cloning of proinsulin genes
ZA824218B (en) *	1981-06-29	1983-04-27	Cetus Corp	Plasmid for producing human insulin
DK368882A (da) *	1981-08-25	1983-02-26	Alan John Kingsman	Expessions vektorer
MC1586A1 (fr) *	1982-03-31	1985-02-22	Genetics Inst	Preparation de sequences d'adn codant pour des precurseurs de pro-insuline modifies
JPS58183659A (ja) *	1982-03-31	1983-10-26	ジェネテイックス、インスチチュ−ト、インコ−ポレ−テッド	修飾プロインシュリン前駆体、これを暗号化するｄｎａ配列およびそれらの産生方法
DK172738B1 (da) *	1983-04-07	1999-06-21	Chiron Corp	Fremgangsmåde til at udtrykke modent insulin og DNA-struktur til anvendelse ved fremgangsmåden
DK129385A (da) *	1985-03-22	1986-09-23	Novo Industri As	Peptider og fremstilling deraf
UA41863C2 (uk) *	1985-10-25	2001-10-15	Займодженетікс Інк.	Спосіб одержання гетерологічного поліпептиду в еукаріотичних мікроорганізмах

1985
- 1985-02-08 DK DK58285A patent/DK58285D0/da unknown
- 1985-05-28 GR GR851304A patent/GR851304B/el unknown
- 1985-05-29 ES ES543594A patent/ES8609483A1/es not_active Expired
- 1985-05-29 US US06/739,123 patent/US4916212A/en not_active Expired - Lifetime
- 1985-05-29 AT AT90121887T patent/ATE143374T1/de active
- 1985-05-29 JP JP60116297A patent/JPH0630613B2/ja not_active Expired - Lifetime
- 1985-05-29 FI FI852135A patent/FI89183C/fi not_active IP Right Cessation
- 1985-05-29 NO NO852132A patent/NO174351C/no not_active IP Right Cessation
- 1985-05-29 PT PT80551A patent/PT80551B/pt not_active IP Right Cessation
- 1985-05-29 NZ NZ212243A patent/NZ212243A/en unknown
- 1985-05-29 EP EP85303775A patent/EP0163529B1/de not_active Expired - Lifetime
- 1985-05-29 EP EP90121887A patent/EP0427296B1/de not_active Expired - Lifetime
- 1985-05-29 DE DE8585303775T patent/DE3583824D1/de not_active Expired - Lifetime
- 1985-05-29 DE DE3588125T patent/DE3588125T2/de not_active Expired - Fee Related
- 1985-05-29 CA CA000482722A patent/CA1304022C/en not_active Expired - Lifetime
- 1985-05-29 AU AU43092/85A patent/AU590197B2/en not_active Ceased
- 1985-05-29 IE IE133185A patent/IE66387B1/en not_active IP Right Cessation
1986
- 1986-02-13 ES ES551941A patent/ES8702488A1/es not_active Expired
1987
- 1987-06-25 DK DK323687A patent/DK157933C/da not_active IP Right Cessation
1993
- 1993-05-24 JP JP5121649A patent/JPH07121226B2/ja not_active Expired - Fee Related
- 1993-05-24 JP JP5121694A patent/JPH0746998B2/ja not_active Expired - Fee Related
1995
- 1995-06-08 JP JP7142085A patent/JP2519023B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU590197B2 (en)	1989-11-02
FI89183C (fi)	1993-08-25
IE851331L (en)	1985-11-30
NO174351B (no)	1994-01-10
ES551941A0 (es)	1986-12-16
FI852135A0 (fi)	1985-05-29
JPH06141866A (ja)	1994-05-24
PT80551A (en)	1985-06-01
JPH07121226B2 (ja)	1995-12-25
EP0163529B1 (de)	1991-08-21
DK157933C (da)	1990-08-27
JPH0746998B2 (ja)	1995-05-24
FI852135L (fi)	1985-12-01
DK157933B (da)	1990-03-05
GR851304B (de)	1985-11-25
DE3588125T2 (de)	1997-02-13
IE66387B1 (en)	1995-12-27
ES543594A0 (es)	1986-09-01
DE3588125D1 (de)	1996-10-31
NO852132L (no)	1985-12-02
US4916212A (en)	1990-04-10
JPH06141865A (ja)	1994-05-24
PT80551B (en)	1987-04-09
CA1304022C (en)	1992-06-23
DE3583824D1 (de)	1991-09-26
FI89183B (fi)	1993-05-14
JPH0630613B2 (ja)	1994-04-27
DK323687D0 (da)	1987-06-25
ES8609483A1 (es)	1986-09-01
AU4309285A (en)	1985-12-05
ATE143374T1 (de)	1996-10-15
EP0427296A1 (de)	1991-05-15
DK323687A (da)	1987-06-25
EP0163529A1 (de)	1985-12-04
EP0427296B1 (de)	1996-09-25
ES8702488A1 (es)	1986-12-16
JPS611389A (ja)	1986-01-07
DK58285D0 (da)	1985-02-08
JPH07309896A (ja)	1995-11-28
NZ212243A (en)	1988-05-30
JP2519023B2 (ja)	1996-07-31

Legal Events

Date	Code	Title	Description
2003-12-29	MM1K	Lapsed by not paying the annual fees	Free format text: LAPSED IN NOVEMBER 2003

Publication	Publication Date	Title
NO174351C (no)	1994-04-20	Fremgangsmåte for fremstilling av human insulinforlöper samt DNA-sekvens og vektor til anvendelse av fremgangsmåten
HUT54213A (en)	1991-01-28	Process for the enzymatic removal of n-terminal sequence of proteins
EP0150126A3 (en)	1987-06-03	The synthesis of protein with an identification peptide
ZA894639B (en)	1991-12-24	Propeptides
HUT43629A (en)	1987-11-30	Process for producing fusion proteins
AU7565991A (en)	1991-11-27	Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy
EP1396542A3 (de)	2004-05-06	P- Selectin Ligandenprotein
DK164940C (da)	1993-02-01	Polypeptid med human-gamma-interferonaktivitet, genteknologisk fremgangsmaade til fremstilling deraf, hybrid-plasmider indeholdende en dna-sekvens, der koder for peptidet, vaertsorganismer indeholdende hybridplasmiderne, samt laegemidler, som indeholder polypeptidet
EP0111389A3 (de)	1985-08-14	Wesentlich sauberes Schweinewachstumshormon, DNS-Sequenzen dafür und Expressionsvektoren und transfektierte Mikroorganismen zur Herstellung von Schweinewachstumshormon
DE293530T1 (de)	1989-11-16	Hormone.
EP0494702A3 (en)	1992-11-19	Production of factor xiiia by gene technology
ATE79409T1 (de)	1992-08-15	Herstellungsverfahren fuer humanes atriales natriuretisches polypeptid.
EP0195680A3 (de)	1987-06-10	Proteinsynthese mit einem Identifizierungspeptid
DE3779711D1 (en)	1992-07-16	Simultaneous solid-phase synthesis of different peptide(s)
EP0232107A3 (de)	1988-04-27	Derivat des menschlichen Lymphotoxin-Polypeptids
ES8506092A1 (es)	1985-06-16	Un metodo de producir un precursor del factor de liberacion de la hormona del crecimiento humana
EP0249412A3 (en)	1989-02-22	C-terminal alpha-amidating enzyme and process for production and use thereof
DK238585A (da)	1985-12-01	Peptider og fremstilling deraf
WO1990000179A3 (fr)	1990-03-08	Nouvelles proteins, adn les codant et leur usage
GB1210557A (en)	1970-10-28	Synthesis of polypeptides containing cysteine
DK301090A (da)	1990-12-19	Insulinprecursorer